advertisement
Sun Y 27
Showing records 1 to 25 | Display all abstracts from Sun Y109829 2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China
Sheng Q
Ocular Immunology and Inflammation 2023; 0: 1-8
109279 Clinical Analysis of Repeat Penetrating Keratoplasty in Children
Sun Y
Journal of clinical medicine 2023; 12:
109809 Association between contrast sensitivity function and structural damage in primary open-angle glaucoma
Pang R
British Journal of Ophthalmology 2023; 0:
110040 RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Fang F
Molecular therapy. Nucleic acids 2023; 33: 286-295
109279 Clinical Analysis of Repeat Penetrating Keratoplasty in Children
Lin Q
Journal of clinical medicine 2023; 12:
109829 2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China
Sun Y
Ocular Immunology and Inflammation 2023; 0: 1-8
109809 Association between contrast sensitivity function and structural damage in primary open-angle glaucoma
Peng J
British Journal of Ophthalmology 2023; 0:
110040 RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Liu P
Molecular therapy. Nucleic acids 2023; 33: 286-295
109829 2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China
Zhai R
Ocular Immunology and Inflammation 2023; 0: 1-8
109809 Association between contrast sensitivity function and structural damage in primary open-angle glaucoma
Cao K
British Journal of Ophthalmology 2023; 0:
109279 Clinical Analysis of Repeat Penetrating Keratoplasty in Children
Song P
Journal of clinical medicine 2023; 12:
110040 RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Huang H
Molecular therapy. Nucleic acids 2023; 33: 286-295
109279 Clinical Analysis of Repeat Penetrating Keratoplasty in Children
Li X
Journal of clinical medicine 2023; 12:
110040 RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Feng X
Molecular therapy. Nucleic acids 2023; 33: 286-295
109809 Association between contrast sensitivity function and structural damage in primary open-angle glaucoma
Sun Y
British Journal of Ophthalmology 2023; 0:
109829 2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China
Fan X
Ocular Immunology and Inflammation 2023; 0: 1-8
109809 Association between contrast sensitivity function and structural damage in primary open-angle glaucoma
Pei XT
British Journal of Ophthalmology 2023; 0:
110040 RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Li L
Molecular therapy. Nucleic acids 2023; 33: 286-295
109829 2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China
Ying Y
Ocular Immunology and Inflammation 2023; 0: 1-8
109279 Clinical Analysis of Repeat Penetrating Keratoplasty in Children
Pan Z
Journal of clinical medicine 2023; 12:
109829 2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China
Kong X
Ocular Immunology and Inflammation 2023; 0: 1-8
110040 RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Sun Y
Molecular therapy. Nucleic acids 2023; 33: 286-295
109809 Association between contrast sensitivity function and structural damage in primary open-angle glaucoma
Yang D
British Journal of Ophthalmology 2023; 0:
110040 RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Kaufman RJ
Molecular therapy. Nucleic acids 2023; 33: 286-295
109809 Association between contrast sensitivity function and structural damage in primary open-angle glaucoma
Lu ZL
British Journal of Ophthalmology 2023; 0:
